article thumbnail

2024 IDstewardship Year End Review

IDStewardship

It is likely our newsletter will remain a key communication for reaching the IDstewardship community.Not knowing what 2025 will hold, it is likely unpredictable events in our future will further guide what activities we engage in this year. Steven Smoke, Pharm.D., It is likely there will be greater activity on Bluesky and less activity on X.

article thumbnail

Five Lessons Learned About Antimicrobial Stewardship Metrics

IDStewardship

Along this line of thought, I have also learned to be gentle with how I communicate my lack of confidence in data that is shared with me. It is critical to recognizethat the data source and system it is filtered through will determinethe quality of the data. It is first important to be grateful to receive information from your colleague.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Women in Pharma® Editorial: Can Communication in a Multigenerational Environment Be Inclusive?

ISPE

Women in Pharma® Editorial: Can Communication in a Multigenerational Environment Be Inclusive? Trudy Patterson Mon, 07/03/2023 - 15:34 Insights July / August 2023 Women in Pharma® Editorial: Can Communication in a Multigenerational Environment Be Inclusive? 4 They also value face-to-face interactions.

article thumbnail

From GRP to SIUU – the Evolution of FDA Guidance on Off-Label Dissemination of Scientific Information

The FDA Law Blog

By Dara Katcher Levy — Yesterday, FDA published a new Draft Guidance, “ Communications from Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Questions and Answers ” (SIUU Guidance or Draft Guidance).

article thumbnail

UK £62 billion behind in R&D global investment share, report reveals

European Pharmaceutical Review

The UK’s share of global research and development ( R&D ) investment has fallen by a fifth since 2014, according to recent data analysis by the Institute for Public Policy Research (IPPR). percent in 2014. percent GDP R&D investment. percent to 3.4 IPPR indicated that state investment drives private sector investment.

article thumbnail

Olivia Buncher, BA, MA

Blog: Ask a Student Pharmacist

Olivia Buncher, BA, MA peck0081 Tue, 04/18/2023 - 08:49 Expand all + Biography Olivia Buncher joined the College of Pharmacy in 2014. in Communication from the University of Minnesota Duluth and her M.A. in Communication from the University of Minnesota Duluth and her M.A. She received her B.A. She received her B.A.

article thumbnail

Norstella, Citeline merge to create $5bn pharma tech firm

pharmaphorum

.” Norstella promises to help drug developers to deal with increasingly large volumes of data, apply real-world data effectively, understand the burden of disease, and communicate the clinical efficacy of a new therapy. Photo by Edge2Edge Media on Unsplash.